Malin logo

MLC - Malin Share Price

€4.5 0.3  7.1%

Last Trade - 14/02/20

Sector
Healthcare
Size
Small Cap
Market Cap £184.4m
Enterprise Value £229.6m
Revenue £29.1m
Position in Universe 820th / 1838
Bullish
Bearish
Unlock MLC Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MLC Revenue Unlock MLC Revenue

Net Income

MLC Net Income Unlock MLC Revenue

Normalised EPS

MLC Normalised EPS Unlock MLC Revenue

PE Ratio Range

MLC PE Ratio Range Unlock MLC Revenue

Dividend Yield Range

MLC Dividend Yield Range Unlock MLC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MLC EPS Forecasts Unlock MLC Revenue
Profile Summary

Malin Corporation plc is an Ireland-based global life sciences company. The Company's businesses include Altan, which is an injectable drug company; AN2H Discovery Limited, which focuses on designing novel small molecule therapeutics; Emba Medical Limited, which offers vascular embolization system; Emba Neuro Limited; Hatteras Venture Partners (HVP), which is a life sciences company; Immunocore, which is a biotechnology company; Jaan Health, which is a healthcare mobile technology company; Kymab Limited, which is a biopharmaceutical company; Melinta Therapeutics, Inc.; Novan, Inc., which is a clinical stage company; Poseida Therapeutics, Inc., which is a human therapeutics company, and Viamet Pharmaceuticals, Inc., which is a drug discovery company. The Company operates through subsidiaries, and focuses on various therapeutic areas, including dermatology, anti-infective, pain, immunology, oncology, neurology, anatomy and other areas.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since March 25, 2015
No. of Shareholders: n/a
No. of Employees: 292
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Irish Stock Exchange
Shares in Issue 49,000,840
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MLC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MLC
Upcoming Events for MLC
Similar to MLC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.